84-2252-52 [取扱停止]Synuclein, alpha, phosphorylated (S129) (SNCA, Alpha-Synuclein, PD1, NACP, PARK1, PARK4) 100ul 213669
特徴
- Alpha-synuclein is a member of the synuclein family, which also includes beta- and gamma-synuclein.
- Synucleins are abundantly expressed in the brain and alpha- and beta-synuclein inhibit phospholipase D2 selectively.
- SNCA may serve to integrate presynaptic signaling and membrane trafficking.
- Defects in SNCA have been implicated in the pathogenesis of Parkinson disease.
- SNCA peptides are a major component of amyloid plaques in the brains of patients with Alzheimer's disease.
- Four alternatively spliced transcripts encoding two different isoforms have been identified for this gene.
- Applications:Suitable for use in Western Blot.
- Other applications not tested.
- Recommended Dilution:Western Blot: 1:500-1:2000Optimal dilutions to be determined by the researcher.
- Storage and Stability:May be stored at 4°C for short-term only.
- Aliquot to avoid repeated freezing and thawing.
- Store at -20°C.
- Aliquots are stable for 12 months after receipt.
- For maximum recovery of product, centrifuge the original vial after thawing and prior to removing the cap.
仕様
- Size:100ul
- Host:rabbit
- Source Antibody:human
- Grade:Affinity Purified
- Purity:Purified by affinity chromatography.
- Form:Supplied as a liquid in PBS, pH 7.3, 0.02% sodium azide, 50% glycerol.
- Specificity:Recognizes SNCA, phosphorylated S129. Species Crossreactivity: human, mouse, rat
- Isotype:IgG
- Calc Applications Abbrev:WB
- Calc Crossreactivity:Hu Mo Rt
- Immunogen:Phospho specific peptide corresponding to residues surrounding S129 of human SNCA.
- Shelf Life:1year
- Swiss Prot Number:P37840
- EU Commodity Code:30021010
- この商品は法規制を確認しておりません。(法規制によって販売できない場合もございます)
- 製品の仕様は予告なく変更になる場合がございます。最新仕様はメーカーホームページをご確認ください。
- 【試薬に関するお問合せ】
- アズワン株式会社 試薬・プロセス材料グループ
- TEL:06-6447-8641
- FAX:06-6447-8642
- E-mail:[email protected]